Wells Fargo Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of $49
Wells Fargo analyst Nathan Treybeck initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight rating and announces Price Target of $49.